NCT02560818 Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer Status COMPLETED Phase NA
NCT02560337 Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy. Status COMPLETED Phase PHASE2
NCT02558348 Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001) Status TERMINATED Phase PHASE1/PHASE2
NCT02545010 Phase I Low Dose WART in Combination With Weekly Paclitaxel for Platinum Resistant Ovarian Cancer Status UNKNOWN Phase PHASE1
NCT02539719 Study of SC-003 Alone and in Combination With ABBV-181 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer Status TERMINATED Phase PHASE1
NCT02537444 Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191) Status COMPLETED Phase PHASE2
NCT02534922 Study of Prolanta™ in Recurrent or Persistent Epithelial Ovarian Cancer Status UNKNOWN Phase PHASE1
NCT02526017 Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Status COMPLETED Phase PHASE1
NCT02517554 A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services Status COMPLETED Phase N/A
NCT02498665 A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies Status COMPLETED Phase PHASE1
NCT02490488 Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients Status COMPLETED Phase PHASE2/PHASE3
NCT02489006 A Study of Olaparib Prior to Surgery and Chemotherapy in Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02483104 Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian Cancer Status COMPLETED Phase PHASE1
NCT02476955 Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole Status TERMINATED Phase PHASE1
NCT02475772 A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis Status COMPLETED Phase PHASE1